Log In
Print this Print this

Synuclere (PD-61-W3)

  Manage Alerts
Collapse Summary General Information
Company ProteoTech Inc.
DescriptionSmall molecule inhibitor of alpha synuclein (SNCA) accumulation
Molecular Target Alpha synuclein (SNCA)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today